3 Common EVALI Symptoms to Recognize

Have you been vaping and started feeling short of breath, unusually tired, or sick in a way that does not feel like a simple cold? EVALI, which stands for e-cigarette or vaping product use-associated lung injury, is a serious lung condition linked to vaping. It can affect breathing, energy, digestion, and overall comfort, sometimes developing over several days or weeks rather than all at once.

EVALI became widely known during the 2019 outbreak in the United States. By February 18, 2020, there were 2,807 hospitalized EVALI cases or deaths reported across all 50 states, Washington, D.C., and two U.S. territories. There were also 68 confirmed deaths in 29 states and Washington, D.C. Those numbers show why vaping-related lung symptoms should not be dismissed, even if someone is young or otherwise healthy.

The symptoms can be confusing because they may look like pneumonia, flu, COVID-like illness, stomach upset, or general exhaustion. Some people notice coughing, chest pain, or trouble breathing first. Others may feel feverish, nauseated, weak, or unable to eat. That overlap makes EVALI hard to recognize without a medical evaluation, especially when a person does not immediately connect their symptoms with vaping.

This article will focus on 3 common EVALI symptoms to recognize and how they may show up in everyday life. The goal is not to make every cough feel frightening. It is to help you notice patterns that may matter, especially if symptoms appear after using vaping products or worsen instead of improving.

What is EVALI (E-cigarette or Vaping use-Associated Lung Injury)?

EVALI is an acute, serious respiratory illness characterized by lung damage and inflammation strongly linked to the use of e-cigarette or vaping products. This condition emerged as a significant public health concern in 2019 following a nationwide outbreak of severe lung injuries among individuals who vaped.

What Does The Term EVALI Mean?

The term EVALI is an acronym that stands for E-cigarette or Vaping product use-Associated Lung Injury, describing lung damage diagnosed in individuals who use these devices after other potential causes have been ruled out. It is not a single, specific disease but rather a clinical diagnosis of exclusion.

This means that when a patient presents with symptoms of lung injury and has a history of vaping, doctors must first eliminate other possible causes, such as bacterial or viral pneumonia (including influenza and COVID-19), autoimmune diseases, or environmental exposures, before assigning an EVALI diagnosis. The process involves a combination of patient history, physical examination, laboratory tests, and, most importantly, imaging studies like chest X-rays or CT scans.

More specifically, the lung damage seen in EVALI can manifest in several ways, reflecting a spectrum of injury patterns. Chemical pneumonitis is a primary form of injury where inhaled chemicals, such as Vitamin E acetate, directly irritate and inflame the lung tissue. This leads to an influx of inflammatory cells and fluid into the alveoli (air sacs), impairing their ability to exchange oxygen and carbon dioxide.

In severe cases, the widespread inflammation can lead to Acute Respiratory Distress Syndrome (ARDS), a life-threatening condition where fluid leaks into the lungs, making breathing difficult or impossible without mechanical ventilation.

Pathologists have also observed patterns resembling organizing pneumonia and diffuse alveolar damage in lung tissue from EVALI patients, indicating a severe and widespread inflammatory response. The diagnosis is ultimately a clinical conclusion that connects a patient’s vaping habits with otherwise unexplained acute lung injury.

Is EVALI a Common Condition?

EVALI is not a common condition; its peak incidence occurred during a significant outbreak in 2019-2020, and while case numbers have declined dramatically, the risk remains for users of certain vaping products, particularly illicit THC cartridges. The outbreak, which spanned from August 2019 to February 2020, was a major public health crisis.

According to the Centers for Disease Control and Prevention (CDC), there were 2,807 hospitalized EVALI cases or deaths reported across the United States during this period. This sudden surge in cases brought the potential dangers of vaping into sharp focus for both the public and the medical community.

The subsequent decrease in reported cases is attributed to several factors. Widespread media coverage and public health campaigns educated consumers about the risks associated with certain vaping products, especially those containing THC obtained from informal sources.

Also, the CDC’s identification of Vitamin E acetate as the primary toxicant of concern led to changes in the formulation of many black-market products and greater caution among users. Healthcare providers became more adept at recognizing the symptoms of EVALI and asking about vaping history, leading to better diagnosis and management.

Despite this decline, it is crucial to understand that the risk has not been eliminated. As long as unregulated vaping products containing harmful additives are available, sporadic cases of EVALI can and do still occur. Furthermore, because it is a diagnosis of exclusion, some cases may be misdiagnosed as other forms of pneumonia if a detailed vaping history is not obtained by the treating physician. Therefore, while no longer at epidemic levels, EVALI remains a potential and severe health risk for the vaping population.

3 Common EVALI Symptoms

Shortness of Breath and Chest Pain

EVALI commonly causes shortness of breath (dyspnea) and chest pain, which can range from a dull ache to sharp, stabbing sensations that worsen with deep breaths. These respiratory symptoms are hallmarks of the condition and are often the primary reason individuals seek medical care. The shortness of breath typically develops gradually over several days or weeks, but in some cases, it can have a rapid and severe onset.

Initially, a person might only feel breathless during physical activity, but as the lung injury progresses, dyspnea can occur even while at rest, making it difficult to speak in full sentences or perform simple tasks. This progressive breathlessness is a direct result of inflammation and fluid accumulation within the lungs’ air sacs (alveoli), which severely impairs the body’s ability to absorb oxygen from the air.

More specifically, the type of chest pain experienced can be a key diagnostic clue. Many patients report sharp, stabbing pain that intensifies with inhalation or coughing. This is known as pleuritic chest pain and indicates inflammation of the pleura, the dual-layered membrane surrounding the lungs. The friction between the inflamed layers during breathing causes the distinct, localized pain.

Others may experience a dull ache or a feeling of tightness and pressure behind the breastbone. This can sometimes be mistaken for cardiac issues, like a heart attack, which is why a thorough medical evaluation, including an EKG and cardiac enzyme tests, is often necessary to rule out other life-threatening conditions.

The combination of worsening shortness of breath and persistent chest pain in an individual with a history of vaping is a major red flag for EVALI and warrants immediate medical consultation.

Nausea and Vomiting

Gastrointestinal (GI) issues such as nausea, vomiting, diarrhea, and abdominal pain are frequently linked to EVALI and can often precede the onset of respiratory symptoms by several days or even a week. This is a particularly important and sometimes confusing aspect of the condition’s presentation.

During the 2019 outbreak, the CDC reported that a majority of hospitalized EVALI patients experienced some form of GI distress. The presence of these symptoms can initially lead both patients and clinicians down the wrong diagnostic path, suspecting conditions like gastroenteritis (“stomach flu”) or food poisoning. However, when these GI issues are accompanied by a history of recent vaping, EVALI should be a primary consideration.

The reason for these systemic effects is believed to be the widespread inflammatory response triggered by the inhaled toxic substances. When chemicals like Vitamin E acetate are inhaled, they can trigger a massive release of inflammatory cytokines into the bloodstream. These inflammatory messengers circulate throughout the body and can affect various organ systems, including the gastrointestinal tract, leading to symptoms of nausea, vomiting, and diarrhea.

The fact that these symptoms can be the very first sign of trouble is a crucial clinical pearl. A patient presenting to an urgent care clinic or emergency room with vomiting and abdominal pain might not be immediately associated with a lung injury. This highlights the absolute necessity for healthcare providers to take a thorough social history, including specific questions about e-cigarette use and the types of products being vaped.

For individuals who vape, the new onset of unexplained GI symptoms should be a warning sign to monitor for any developing respiratory issues and to consider seeking medical advice.

Fever and Fatigue

EVALI can cause a range of constitutional or systemic symptoms, including fever, chills, fatigue, and unintentional weight loss, which often mimic common viral illnesses like influenza. These generalized, flu-like symptoms are another key feature of the systemic inflammation that characterizes EVALI. Their non-specific nature makes early diagnosis exceptionally difficult, especially during cold and flu season.

A person might initially dismiss their symptoms as a common cold or flu, delaying medical care until more severe respiratory symptoms, like shortness of breath, develop. Many patients hospitalized with EVALI reported experiencing several days of fever, drenching night sweats, and a profound sense of malaise and fatigue before their breathing became seriously compromised.

The clinical presentation can be very similar to infectious pneumonia, complicating the diagnostic process. The fever associated with EVALI is typically low-grade but can sometimes be high (above 100.4°F or 38°C). It is often accompanied by chills or rigors, which is the body’s response to the systemic inflammatory cascade.

The fatigue can be overwhelming and disproportionate to the other symptoms, leaving individuals feeling completely drained of energy. This, combined with a general feeling of being unwell (malaise) and a potential loss of appetite leading to weight loss, paints a picture of a significant systemic illness.

When these constitutional symptoms appear in someone who vapes, especially if they are not improving after a few days or are accompanied by any GI or respiratory complaints, EVALI must be considered. The combination of flu-like symptoms, gastrointestinal distress, and breathing difficulties in a vaper creates a classic triad that strongly suggests the possibility of this serious lung injury.

What causes EVALI?

Vaping products most often linked to EVALI are those containing tetrahydrocannabinol (THC), particularly cartridges obtained from informal or illicit sources, which frequently contain Vitamin E acetate as a cutting and thickening agent. Laboratory data from the CDC’s investigation showed a powerful connection.

Vitamin E acetate was identified in the lung fluid samples (obtained via bronchoalveolar lavage) from a staggering 48 out of 51 EVALI patients from 16 states, but it was not found in the lung fluid of healthy comparison subjects. This provided compelling evidence of its role in the lung injury.

This substance is an oily chemical that, while safe when ingested as a supplement or applied to the skin, appears to interfere with normal lung function when inhaled. It is believed to disrupt the pulmonary surfactant, a thin layer of fluid lining the alveoli that is essential for proper breathing mechanics.

The greatest risk comes from the unregulated market. The overwhelming majority of patients with EVALI reported using THC-containing products acquired from informal sources like friends, family, or online dealers rather than from licensed dispensaries. These black-market products are not subject to any form of quality control or safety testing, making them a gamble.

Besides, vitamin E acetate became a popular additive in illicit THC cartridges because it is visually similar to THC oil and is an effective thickening agent, allowing manufacturers to dilute the more expensive THC oil without the consumer noticing a difference in the liquid’s consistency.

While the link is strongest with these illicit THC products, a small percentage of EVALI patients reported using only nicotine-containing products. This suggests that other chemicals or contaminants in vaping liquids could also potentially cause lung injury, reinforcing the general advice from public health officials to refrain from using any e-cigarette or vaping products, particularly those from unverified sources.

When to Seek Medical Help?

Warning signs of severe EVALI requiring immediate medical attention include severe difficulty breathing or gasping for air, persistent and intense chest pain, confusion or altered mental state, and cyanosis (bluish discoloration of the lips or face).

These symptoms indicate that the lung injury has progressed to a critical stage where the body is not receiving enough oxygen, a condition known as hypoxia. This is a medical emergency that can rapidly lead to respiratory failure, multi-organ damage, and even death if not treated promptly. It is absolutely vital for anyone who vapes, or their family members, to recognize these red-flag symptoms and seek emergency care without delay.

Specifically, severe shortness of breath (dyspnea) is more than just feeling a little winded. It involves struggling to breathe, being unable to speak in full sentences, feeling a sense of suffocation, or using accessory muscles in the neck and chest to try to draw in air.

While some chest pain is common with EVALI, pain that is crushing, severe, and does not subside with rest could indicate significant lung inflammation or another serious condition like a heart attack.

When oxygen levels in the blood drop dangerously low, it can manifest in several ways. Cyanosis, a bluish tint to the lips, face, or fingernail beds, is a classic sign. Additionally, the brain is very sensitive to low oxygen, which can cause confusion, disorientation, extreme lethargy, or difficulty staying awake.

Also, a very high fever that does not respond to over-the-counter fever-reducing medications can be a sign of a severe systemic inflammatory response or a secondary infection.

If any of these symptoms are present, especially in an individual with a known history of vaping, you should call 911 or go to the nearest emergency department immediately. Do not attempt to wait it out at home. When seeking care, it is critical to inform the medical staff about the use of e-cigarettes or vaping products, including what substances were vaped (THC, nicotine, etc.) and where they were obtained, as this information is vital for an accurate and timely diagnosis.

EVALI Diagnosis

Diagnosing EVALI is primarily a process of elimination, as there is no single definitive test for the condition. The first and most critical step is a thorough patient history, with a specific focus on the use of e-cigarette or vaping products within the 90 days preceding symptom onset.

Clinicians will ask detailed questions about the types of products used, particularly those containing THC (tetrahydrocannabinol), the source of these products (commercial vs. informal), and the frequency of use.

If a history of vaping is established, the next step involves chest imaging. A chest X-ray is often the initial test, but a chest CT (computed tomography) scan provides a more detailed view of the lungs. The hallmark finding on a CT scan for EVALI is the presence of diffuse, bilateral ground-glass opacities, which appear as hazy areas indicating inflammation and fluid in the lungs.

To confirm the diagnosis, doctors must systematically rule out other possible causes of lung injury, especially infections. This involves a series of laboratory tests, including blood tests to check for markers of infection and inflammation, a respiratory viral panel to test for common viruses like influenza and RSV, sputum cultures to identify potential bacterial infections.

In some complex cases, a procedure called bronchoalveolar lavage (BAL) may be performed. During a BAL, a sterile solution is washed into a small section of the lung and then collected for analysis to rule out infection and sometimes to test for substances like vitamin E acetate, a chemical additive strongly linked to the EVALI outbreak.

Potential Long-term Effects of EVALI

While many individuals who develop EVALI recover with medical treatment, a significant portion may experience lasting health consequences. The long-term effects depend on the initial severity of the lung injury, but research and patient follow-ups have identified several potential outcomes. One of the most common concerns is a persistent reduction in lung function.

Survivors may find themselves easily winded during physical activity, experience a chronic cough, or require ongoing respiratory support long after being discharged from the hospital. This diminished capacity is often due to inflammation-induced damage to the delicate lung tissues responsible for gas exchange.

In more severe cases, EVALI can lead to permanent lung scarring, a condition known as pulmonary fibrosis. This scarring makes the lung tissue stiff and less elastic, permanently impairing its ability to expand and contract, which can lead to chronic shortness of breath and the need for long-term oxygen therapy.

Beyond the physical repercussions, the experience of a life-threatening illness can have a significant psychological impact. Many survivors report experiencing anxiety, depression, or post-traumatic stress disorder (PTSD) related to their hospitalization and respiratory distress.

Other potential long-term concerns that require ongoing monitoring include increased susceptibility to future respiratory infections, the need for continued use of medications like corticosteroids or inhalers to manage lingering inflammation, and regular follow-up appointments with a pulmonologist to monitor lung function through tests like spirometry.

EVALI vs. Bacterial Pneumonia or COVID-19

Distinguishing EVALI from other common lung conditions like bacterial pneumonia and COVID-19 is a critical diagnostic challenge, as their initial symptoms often overlap. However, key differences in their cause, typical presentation, and imaging findings help clinicians make an accurate diagnosis. EVALI is a chemical-induced injury, not an infection, primarily linked to inhaling vitamin E acetate found in illicit THC vaping products.

In contrast, bacterial pneumonia is caused by a bacterial pathogen, such as Streptococcus pneumoniae, while COVID-19 is caused by the SARS-CoV-2 virus. This fundamental difference in origin dictates the treatment approach: EVALI is managed with supportive care and anti-inflammatory corticosteroids, whereas bacterial pneumonia requires antibiotics, and COVID-19 is treated with antiviral medications.

The symptom profiles also offer clues. While all three can cause cough, fever, and shortness of breath, EVALI is frequently preceded by significant gastrointestinal symptoms like nausea, vomiting, and diarrhea. Bacterial pneumonia often presents with a productive cough (with phlegm) and chest pain localized to one area. COVID-19 has a broader range of symptoms that can include the distinct loss of taste or smell.

Official Guidance on Preventing EVALI

The most effective way to prevent EVALI is to follow the clear and direct guidance issued by public health authorities like the Centers for Disease Control and Prevention (CDC). The primary and most unequivocal recommendation is to refrain from using any e-cigarette or vaping products, particularly those that contain THC.

The vast majority of EVALI cases have been linked to THC-containing products, making them the highest-risk category. For those who do not currently use tobacco products, the CDC advises against starting to use e-cigarettes or any other vaping device for any reason.

For individuals who continue to vape, several specific harm-reduction strategies are strongly recommended to minimize the risk of developing EVALI. The most critical piece of advice is to never acquire vaping products from informal or unregulated sources. This includes buying from friends, family members, or any illicit online or in-person dealers. Products from these sources are not subject to any quality control and are far more likely to contain dangerous additives like vitamin E acetate.

Furthermore, do not modify or add any substances to vaping products that were not intended by the manufacturer. This includes adding THC oil, other oils, or diluents to commercially purchased e-liquids.

Adult smokers who have completely switched to vaping should be vigilant about monitoring themselves for symptoms such as cough, shortness of breath, chest pain, or gastrointestinal issues, and seek prompt medical attention if they arise. Youth, young adults, and pregnant individuals should not use e-cigarette or vaping products under any circumstances.

FAQs

1. Can EVALI heal on its own?

EVALI should not be treated as something to wait out at home. Some mild breathing irritation from vaping may improve after stopping, but true EVALI can become serious and may require oxygen, imaging tests, medication, or hospital care.

During the 2019 outbreak, the CDC reported 2,807 hospitalized EVALI cases or deaths and 68 confirmed deaths by February 18, 2020, which shows how severe this condition can become. If someone who vapes develops chest pain, shortness of breath, worsening cough, fever, vomiting, or extreme weakness, medical evaluation is important.

2. How do you feel with EVALI?

EVALI can feel like a mix of lung illness, flu-like sickness, and stomach upset. A person may have shortness of breath, coughing, chest pain, fever, chills, tiredness, nausea, vomiting, diarrhea, or poor appetite.

Some people feel worse with activity because the lungs are not moving oxygen well. Others may feel generally sick before breathing symptoms become obvious. Reports from early EVALI cases commonly described symptoms such as shortness of breath, nausea, and fever.

3. How long do you have to vape to develop EVALI?

There is no safe timeline. EVALI has been linked to vaping product use within the 90 days before symptoms begin, according to CDC surveillance criteria.

Some people may develop symptoms after repeated use, while others may become sick after a shorter period, especially if the product contains harmful additives or contaminants. Risk may also depend on what was vaped, how often, the source of the product, and a person’s lung health.

4. Is 10 puffs of vape a day bad?

Yes, even 10 puffs a day can be harmful. Vaping can expose the lungs to nicotine, ultrafine particles, flavoring chemicals, heavy metals, and other substances that may irritate or damage lung tissue.

Fewer puffs may mean less exposure than heavy use, but it does not make vaping safe. For someone with cough, wheezing, chest tightness, or shortness of breath, continuing to vape may make symptoms worse.

5. How long for EVALI?

EVALI recovery time varies. Some people improve over days or weeks after treatment and stopping vaping. Others may take longer, especially if lung injury is severe or if they needed oxygen, intensive care, or a ventilator.

Follow-up is important because breathing symptoms can return or linger. The CDC stopped collecting national EVALI case counts in February 2020 after cases declined, but EVALI remains a serious condition linked to vaping exposure.

6. Does EVALI come on suddenly?

EVALI can come on suddenly, but it may also build gradually over several days or weeks. Some people first notice mild cough, tiredness, fever, nausea, or chest discomfort before breathing becomes more difficult.

Others feel a faster decline, with shortness of breath or chest pain becoming severe enough to need urgent care. A sudden change in breathing after vaping should always be taken seriously.

7. How painful is EVALI?

EVALI can be painful for some people, especially when it causes chest tightness, chest pain, coughing, or pain with deep breaths. Others may describe more discomfort than sharp pain, along with breathlessness, fever, nausea, or exhaustion.

Pain level does not always match severity. A person can have serious lung inflammation even if the pain is mild, so worsening breathing symptoms matter more than pain alone.

Conclusion

EVALI is not just a bad cough or ordinary vaping irritation. It is a serious lung injury that can affect breathing, energy, digestion, and overall health. Symptoms such as shortness of breath, chest pain, cough, fever, nausea, vomiting, diarrhea, or unusual fatigue should not be ignored, especially when they appear after vaping.

The difficult part is that EVALI can look like other illnesses. It may feel like flu, pneumonia, stomach infection, or a general viral sickness. That overlap makes it easy to underestimate early warning signs. Still, a pattern of breathing trouble, chest discomfort, and recent vaping exposure deserves prompt attention.

Stopping vaping is one of the most important steps, but someone with possible EVALI may need medical care to check oxygen levels, lung inflammation, infection, or other causes. If symptoms are severe, sudden, or worsening, getting urgent help can protect the lungs and prevent complications.

Recognizing the signs early gives a person a better chance to act before the condition becomes more dangerous.

References

• The Johns Hopkins University – What Does Vaping Do to Your Lungs?
• American Lung Association – E-cigarette or Vaping Use-Associated Lung Injury (EVALI)
• National Library of Medicine – Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury
• American Thoracic Society – E-cigarette or vaping product use-associated lung injury (EVALI)
• CDC – Frequently Asked Questions
• Yale Medicine – E-cigarette, or Vaping Product, Use Associated Lung Injury (EVALI)
• University of Utah Health – What Vaping Really Does to Your Lungs
• The Royal Australian College of General Practitioners – What is EVALI?
• UNC Health – UNC Researchers Tackle the E-cigarette or Vaping Product Use–associated Lung Injury (EVALI) Epidemic